Two different machine-learning algorithms have been used to predict the blood-brain barrier permeability of different classes of molecules, to develop a method to predict the ability of drug compounds to penetrate the CNS. The rst algorithm is based on a multilayer perceptron neural network and the second algorithm uses a support vector machine. Both algorithms are trained on an identical data set consisting of 179 CNS active molecules and 145 CNS inactive molecules. The training parameters include molecular weight, lipophilicity, hydrogen bonding, and other variables that govern the ability of a molecule to diffuse through a membrane. The results show that the support vector machine outperforms the neural network. Based on over 30 different validation sets, the SVM can predict up to 96% of the molecules correctly, averaging 81.5% over 30 test sets, which comprised of equal numbers of CNS positive and negative molecules. This is quite favorable when compared with the neural network's average performance of 75.7% with the same 30 test sets. The results of the SVM algorithm are very encouraging and suggest that a classi cation tool like this one will prove to be a valuable prediction approach.
INTRODUCTION P
redicting the ability of a molecule to enter the central nervous system (CNS) through the bloodbrain barrier (BBB) would be an extremely useful tool for designing drug compounds. Designing drugs for targets in the CNS is a dif cult task because of the presence of the blood-brain barrier. The BBB is a selective membrane that prevents small molecules from entering the CNS, making drugs that are effective in other parts of the body virtually useless for CNS targets. As a result, bacterial and viral infections can harbor in the CNS, making it dif cult to fully eliminate the infection through conventional antibiotic therapies. As a preliminary step to designing more useful drugs that can act on targets in the
MATERIALS AND METHODS

The drug database
The database is comprised of 324 drugs and biologically active molecules that have been accumulated from several sources to make up the training set (Appendix A). These molecules were taken from previous papers discussing BBB transport, primarily Fischer et al. (1998) , Ajay et al. (1999) , and van de Waterbeemd et al. (1998) . These resources did not provide a suf cient number of molecules for training, so additional molecules were identi ed from the psychotropic database (Lundbeck et al., 2000) , the Physicians' Desk Reference, and the National Library of Medicine's Medline Plus Health Information website. The CNS activity of each molecule was determined by one of three general classi cation factors: previously published results, where the molecule was considered to be CNS active or inactive; whether or not the molecule was listed in the psychotropic database, where all listed molecules are considered to be CNS active; and nally, the medical use, mechanism of action, and contraindications of the molecule. The chemical and physical descriptors of the molecules were obtained from the NCI structural and physical properties database produced by ChemSW.
The neural network
The neural network algorithms have been implemented using the Matlab Neural Net Toolbox. This software package provides the functions necessary to build and train a backpropagation network. The Neural Net Toolbox contains several training algorithms that are all variations on the general algorithm described above. In this study, the resilient backpropagation algorithm was used to reduce the time necessary to train the network. This algorithm works on the same principles as the gradient descent algorithm; however, instead of using the product of the activation and the error of the node, it uses only the sign of this value to determine the change in the weight.
The backpropagation network uses a sigmoidal squashing function to provide a continuous activation function. The nature of this function is that its slope approaches zero at the extreme values, so the product of the derivative of the activation and the error is often a very small value. This leads to very small changes in the weight, resulting in very slow training. The resilient backpropagation algorithm uses a separate parameter to determine the size of the step it takes when calculating a new weight. This parameter is slightly increased each time the derivative of the performance function has the same sign for two successive iterations with respect to the weight. The parameter is decreased when the sign of the derivative changes from the previous iteration. This modi cation from the original gradient descent algorithm reduced the time necessary to train the network by at least an order of magnitude.
The support vector machine
The SVM used in this study was implemented using the SVM Light package available from Thorsten Joachims (www.ais.gmd.de/»throsten/svm_light). This software package implements a classi cation algorithm, which is based on the soft margin algorithm. The SVM Light package provides four different kernel methods: a linear kernel, a polynomial kernel, a radial basis function kernel, and a sigmoidal kernel. In addition to choosing the kernel function, the architecture of the SVM can also be modi ed by a training parameter (called C) that sets the tradeoff between training error and the margin size. The kernel function and the speci city of the training parameter proved to be the most signi cant factors when optimizing the SVM algorithm (see results below).
Training times for the SVM varied signi cantly with the kernel function. The radial basis function (RBF) was the fastest, with training taking less than 0.5 seconds of CPU time on a Sun UltraSparc. The quadratic kernel was signi cantly slower, taking 350 seconds on average for training with a C value of 5. The SVM using the RBF kernel carries out the training signi cantly faster than the NN, which had training times that were at least 100 times slower for the identical training sets.
Measuring the predictive performance of the algorithms
For both the NN and the SVM, the performance of the algorithm was measured by counting the number of molecules in the validation set that were correctly classi ed. One of the standard methods for evaluating machine learning algorithms is the cross validation method, where the data set is split into three equally sized groups and then the training is carried out on two thirds of the data points and the remaining third is used for validation. In this study, the data set is quite small compared to other machine learning problems, so cross validation makes the training set too small to well represent the problem.
A different method for validation has been used here that is based on a "bootstrapping approach," as follows. The validation set is made up of 50 molecules: 25 CNS active and 25 CNS inactive molecules are selected at random from the complete data set. To get an accurate measure of the algorithm's predictive performance, 30 different validation sets were used. The NN or SVM was trained independently for each of the 30 validation sets, and the average performance over all 30 validation sets is taken as the predictive ability of the algorithm.
RESULTS
Designing the neural network
To optimize the performance of the network, several parameters were modi ed during training of the network including the number of hidden units and the stopping error of the training algorithm. One of the complications in using neural networks is that there is no way to predetermine what the optimal values for these parameters should be. Each data set is unique and each network is unique, so there are no rules de ning the optimal level of training or the optimal number of hidden units. There are several common heuristics that can be followed to reach a point where the network's performance is "good enough," even if it is not completely optimized.
DONIGER ET AL.
In this study, a descriptor set of nine variables is used as inputs to the neural network. The input set consists of molecular weight, molecular volume, surface area, the percent of the surface area that is hydrophilic, the log P (octanol/water partitioning coef cient), the number of hydrogen bond donors, the number of hydrogen bond acceptors, the hydrophilic/lipophilic balance, and a three-dimensional representation of the number of hydrogen bonds. These variables were decided on based on the parameters previously determined to be important in BBB transport (Pardridge, 1998; Crivori et al., 2000; Fischer et al., 1998) as well as on the information available from the ChemSW database. Passive diffusion is the primary method of transport looked at in this study, and each of these variables is important in determining the ability of a molecule to diffuse through a lipid bilayer.
The performance of the network suggests that these input parameters are adequate for predicting the CNS active molecules, but that additional descriptors may be necessary for describing the CNS inactive molecules. This is most likely due to the presence of the ef ux proteins, which remove many molecules that are capable of penetrating the BBB.
The values obtained from the ChemSW database are normalized to a mean of zero and a unit standard deviation before being used to train the network. Using the normalized data is advantageous because it prevents one input from dominating the training process. In this data set, the molecular weight has a much larger variance than the log P or hydrogen bonding values, so if the actual data values are used, the network will be heavily weighted for the molecular weight. This could lead the network to view molecular weight as a more important input variable than it actually is, skewing the results.
The number of hidden units in the network is generally thought to be an important variable because the hidden units act as the pattern identi ers during the training. A general heuristic is that the number of hidden units should be equal to the number of patterns expected in the data set. The number of hidden units should also be less than the number of data points in the training set. As the number of hidden units approaches the number of data points in the training set, the network becomes merely a lookup table, rather than a network that can generalize from the inputs.
For this speci c network, there does not appear to be one optimal value for the number of hidden units. Our results show that performance increases with the number of hidden units, up to 60 hidden units, and then the performance remains consistently in the high 70% range (Fig. 1) . In addition to these results, many other tests have been run and results have been highly variable, such that for any given data split there is a different optimal number of hidden units. For this study, the results are given for hidden unit values of 45 and 60. Networks of this size have consistently been some of the best performers and should provide an adequate representation of the predictive powers of the network. Continuing above 60 hidden units was not necessary because there is only a slight increase in performance, and this increase did not merit the substantial increase in training times.
FIG. 1.
The number of hidden units versus the performance of the NN. From this graph, it can be seen that the performance of the network increases as the number of nodes increases, but then levels off above 60 hidden units. The stopping error, or the point where the network has trained enough, is determined by an errorchecking procedure known as early stopping. In early stopping, the data set is split into three sets, the training set, the validation set, and the testing set. As the network is trained, the performance of the network is measured on the validation set. When the error on the validation set begins to increase, which indicates that the network has begun to over t the data, the training stops. The validation set is then added back into the training set and the network is trained brie y with the combined training set, so that the validation can also be used to generalize for the testing set.
PREDICTING CNS PERMEABILITY OF DRUG MOLECULES
Implementing this early-stopping algorithm actually decreased the performance of the network by an average of nearly 3.5%. This result was very unexpected, as early stopping should typically lead to an improved performance on the test set. One possible explanation for this result is that because of the small size of the data set, removing the validation set from the training set makes the training set too small to properly train the network. Removing an additional 50 molecules for the validation set leaves only 274 molecules to train the network. The validation set is added back into the training set once the early stopping has occurred and the network is brie y trained on this larger training set. It is possible that because the network only sees these additional 50 molecules following the early stopping, this does not provide suf cient training time to fully incorporate these molecules into the weighting of the network.
In order to avoid using a smaller training set, a different form of early stopping that does not split the training set has been implemented. In this method the stopping error is predetermined before the training begins. Using decreasing stopping errors, it was possible to determine the optimal stopping point for the network. The network's performance quickly improves as the mean squared error of the training set decreases, but then begins to plateau and then begin a slow descents as the MSE decreases further (Fig. 2) . These results agree with the theory behind the early stopping algorithm, and the peak of this graph was used as the target error when training the network.
The performance of the neural network
Two different networks have been used to measure the predictive ability of the neural network. The networks use the normalized data, a target-training mean squared error of 0.2, and either 30 or 45 hidden units. Each network has one output node, which uses a tangent sigmoidal function to con ne the output values between ¡1 (CNS inactive) and 1 (CNS active). Over 30 different test sets (each test set consists of 25 CNSC and 25 CNS¡ molecules selected at random from the data set and are withheld from training) the neural network correctly predicted 75.7% of the molecules when using 30 hidden nodes and 75.0% of the molecules when using 45 hidden nodes. The network correctly classi ed 81.5% of the CNS active molecules and 69.9% of the inactive molecules. 
Design of the support vector machine
In this approach, three different kernel methods were compared: (i) a linear kernel that essentially used the 275 dimensional input space as the feature space; (ii) a quadratic function that produced a slightly more complicated decision surface by looking at the relationships between pairs of inputs; and (iii) a radial basis function (RBF) which uses a Gaussian equation to map the inputs to an even more complicated feature space. In addition, higher-degree polynomial functions and a sigmoidal function were also tested as possible kernel functions, but they did not outperform any of the kernels described here.
For each of the kernel functions, four different levels of training speci city were compared to see which led to the best performance. The training error is controlled by the parameter C of the learning algorithm. The initial algorithm, with C equal to 0, led to 30 training points being misclassi ed. As the penalty for misclassifying data increases, the number of misclassi ed data points decreases so that for C equal to 5, only 3 data points are misclassi ed on average, and for C equal to 10, this number drops to 2. Table 1 shows how adjusting the training error affected the performance of the three different kernel methods.
From Table 1 it can be seen that the RBF kernel is the best kernel function for classifying this data set. The results also show that using a C value of 5 leads to the optimal level of training and the best performance of this kernel function. A SVM with a RBF kernel function and C set to 5 was therefore used to predict the ability of the drug molecules to penetrate the BBB.
Performance of the support vector machine
The SVM was trained in parallel with the NN system. The total database of molecules consists of 324 molecules, of which 50 molecules (25 CNSC and 25 CNS¡) were selected at random and used as the validation set, leaving 274 molecules to be used for training. Each molecule was represented by the same nine parameters used in the NN training. The number of molecules correctly classi ed in the validation set is used to measure the performance of the SVM. In order to obtain a more accurate measure of the performance, 30 different splits of the data were used to calculate the average performance of the SVM.
SVM's overall average in correctly classifying both CNSC and CNS¡ molecules was 81.5% over the 30 different data splits. The performance ranged from a low of 66% to a high of 96%, with a median and mode value of 82%. When looking at the performance on the CNSC and CNS¡ subsets, the SVM correctly classi ed 82.7% of the CNSC molecules and 80.2% of the CNS¡ molecules. The ability to accurately predict not only CNSC but also CNS¡ compounds highlights the strength of the SVM over the NN approach.
Pruning the descriptor set
As the level of complexity increases during machine learning, the resulting decision surface becomes more speci c to the particular data set and often the level of generalization decreases with increased complexity. In order to determine if the descriptor set used here was leading to overly speci c training and poor generalization, training was attempted in the absence of each descriptor to see if the performance would increase. Removing any of the descriptors actually lowered the performance of the SVM (Table 2 ). The hydrogen-bonding characteristics have the largest impact on the data, lowering the performance by 7.2%. No other parameter had a signi cant impact on the performance of the SVM. Several smaller combinations of the parameters were used to train the SVM to see if a better training set could be identi ed. Using just the hydrogen bonding characteristics, the SVM's performance only decreased by 6.2%, again showing the a From left to right, log P is the octanol/water partitioning coef cient, followed by the molecular weight, volume, surface area, percent of hydrophillic surface area, hydrogen bond donors/acceptors and 3D hydrogen bonding, and the hydrophilic-lipophilic balance. The nal column shows the results of training with log P and the hydrogen bonding characteristics alone. importance of these parameters. When log P was added back in, so that the SVM was trained with the hydrogen bonding and log P descriptors only, the performance was decreased by just 4%. A very interesting result is that when log P and hydrogen bonding were removed from the descriptor set, the learning algorithm did not converge, meaning the SVM could not classify the molecules in the absence of these two parameters. This indicates that the primary descriptors being used for classi cation are the hydrogen bonding descriptors and the log P descriptors. However, the remaining parameters should not be ignored because they do enhance the performance of the SVM.
Analysis of false positive and false negative outputs
To get a better understanding for why 20% of the molecules are being misclassi ed, the outputs from 10 different test sets have been analyzed. These test sets give a broad selection of the molecules in the database, and through the repetition of some molecules in multiple testing sets, it is possible to identify common themes among the false positive and false negative results. Molecules that were misclassi ed at least twice, or molecules that were severely misclassi ed (i.e., a molecule that is CNS¡, but the SVM reports a score of C1 or greater) were identi ed as false positives or negatives. In the 10 test sets, 10 molecules were identi ed as false negatives and 15 molecules were identi ed as false positive (Table 3) .
The results show that the false positive molecules are signi cantly smaller, more lipophilic, and have fewer hydrogen bond donors and acceptors (Table 4) . This is all consistent with the expected model that CNS positive molecules are small, lipophilic molecules. One of the most obvious classes of molecules that appear in the false positive set is the antihistamines. Mepiramine and pheniramine are H1 agonists and are classi ed as CNS inactive, but other antihistamines such as diphenhydramine are classi ed as CNS active. The structure of pheniramine and diphenhydramine are quite similar and pheniramine actually has a higher log P value and fewer hydrogen bonds, so this would seem to make it more likely to cross the BBB than diphenhydramine. Another molecule that stands out is hyoscyamine. This molecule is an anticholinergic drug, classifying it as CNS inactive. However, the SVM predicted outputs of 1.69 and 1.62 for this molecule, suggesting that it very easily penetrate the BBB. In this study, BBB permeability is equated with CNS activity, and as these results suggest, this simpli ed method of classi cation can be somewhat misleading. There are molecules that have the physical ability to cross the BBB, but then do not interact with any speci c receptor in the CNS, making them CNS inactive, but capable of penetrating the BBB.
The false-negative compounds are less lipophilic than the average CNS active compounds. What is interesting is that these molecules are signi cantly smaller than the rest of the CNS active molecules. The smaller size of these molecules can also account for some of the decrease in the log P values. In general, the algorithm misclassi es fewer CNS active molecules than CNS inactive molecules; this could be due to the fact that the CNS active molecules have less variance in the values for the 9 descriptors than the CNS inactive molecules. This can also be attributed to the fact that there is less ambiguity in classifying CNS active molecules than classifying CNS inactive molecules.
Analysis of the outputs of the NN and SVM
The goal of this study is not only to design a method of classifying drug molecules based on the ability to enter the CNS but to also use this information to classify potential drug molecules in drug design screens. Neural networks and support vector machines are binary classi ers capable of separating a complicated data set into two distinct classes. The outputs from these algorithms range from ¡1 to C1 for the NN algorithm and, while for SVM there are no bounds on the output, in general they range between ¡1.8 and C1.8. If these outputs are to be used for designing molecules speci cally targeting the CNS, it would be a great advantage if the outputs could be used as a quantitative measure of BBB permeability.
The test sets of the SVM were rst searched for molecules with similar structures. Ideally, if the outputs are proportional to BBB permeability, then molecules with similar structure should have similar output. In test set 1, both apomorphine and morphine are present. Apomorphine is synthesized from morphine and these molecules are similar chemically although dissimilar pharmacologically in that they interact with different receptors. However, looking at the results of the SVM, you would not know this. Apomorphine is assigned an output of 0.03, making it only slightly CNS active. Morphine on the other hand is assigned an output of 0.99, making it a de nite CNS active molecule, as one would expect. The output for morphine is encouraging, although we continue to work towards enhancing the performance of the algorithm so that apomorphine can be correctly predicted.
Test set 9 contains both temazepam and medazepam and they are assigned values of 0.80 and 0.58, respectively. These molecules are both anxiolytic compounds and are both CNS active. They have similar structures and differ in that temazepam contains a carbonyl and a hydroxyl group that are not present in medazepam. This raises the level of hydrogen bonding in temazepam and lowers its log P value. Based on these facts, it would seem that temazepam should be less able to penetrate the BBB, but the SVM algorithm scores temazepam higher than medazepam.
In another set of test sets (data not shown) clomipramine and imipramine are assigned outputs of 1.72 and 1.03, respectively. These molecules are both tricyclic antidepressants and differ only in the addition of a chlorine atom in clomipramine. The two molecules have identical hydrogen bonding characteristics and their log P values differ by only 0.5. It is dif cult to say if clomipramine is really 70% more able to cross the BBB, but it encouraging that two similar obvious CNS active structures both received high positive outputs. Clomipramine appears in 4 of the 10 test sets and is assigned values of 0.77, 0.92, 1.65, and 1.72. These values show that across different training sets the actual values of the outputs cannot be simply compared because of variations within the training set which leads to different weights and, consequently, varying the outputs.
The important question is how do these outputs for clomipramine compare to the rest of the testing set. Clomipramine is consistently one of the highest outputs of the testing sets. In the two test sets where clomipramine was assigned values below 1, none of the molecules in the test set were assigned values above 1, showing that relative to the other molecules in the test set clomipramine can consistently be considered to easily cross the BBB. Two additional test sets have been created to test the ability of the algorithm to rank closely related molecules. The rst test set contains the tricyclic antidepressants, clompiramine, imipramine, desipramine, trimipramine, and doxepin. The second test set contains codeine, hydrocodone, and oxycodone, three narcotic analgesics with related structures. The SVM was trained using all of the remaining molecules in the data set (319 molecules and 321 molecules, respectively), so these test sets can be thought of as novel molecules, simulating a design situation.
The results from the tricyclic compounds are encouraging (see Fig. 3 ). First, all ve molecules are correctly classi ed as CNS+ molecules, which shows that the SVM is effective in binary classi cation. Second, the molecule with the highest hydrogen bonding has the lowest predicted BBB permeability. This result is consistent with the expected negative correlation between hydrogen bonding and BBB permeability. Of the four remaining compounds, clomipramine receives the highest score and trimipramine the lowest. This result is somewhat surprising. One would expect that the polar nature of the chlorine atom in clomipramine would reduce its BBB permeability and the additional methyl group in trimipramine would raise its BBB permeability. Unfortunately, no data is currently available on the actual logBBB (blood-brain barrier partitioning coef cient) of these molecules, so that these results predicted by the algorithm remain to be con rmed.
The results of the narcotic analgesics are also encouraging (see Fig. 4 ) because again the molecule with the most hydrogen bonding, oxycodone, has the lowest predicted BBB permeability. It is interesting that hydrocodone has a predicted BBB permeability that is half of codeine. This suggests that hydrogen bond acceptors may hinder crossing the BBB more than hydrogen bond donors do. Again, there is a lack of experimentally determined values of BBB permeability, and the predicted results remain to be experimentally con rmed.
The results from comparing the various test sets and from the smaller speci c test sets suggest that the outputs given by the SVM can be viewed as preliminary predictions for BBB permeability. As the exact values of predictions are only meaningful within the context of the speci c test set, the output for any particular compound cannot be taken as a quantitative value. Values generated between test sets cannot be quantitatively compared because of variations in the training sets that alter the weights of the classi cation function and thus the scale of the outputs. Nevertheless, this SVM methodology appears to be an excellent starting point for narrowing down a large library of potential drug molecules. 
DISCUSSION
The support vector machine outperforms the neural network
This study has compared the ability of two different machine-learning algorithms to predict the ability of drug molecules to cross the BBB and enter the CNS. The results show that over the same data set, using identical training and validation sets, the support vector machine outperforms the neural network by about 6% (81.5% to 75.7%). The result of the SVM algorithm is very encouraging, as it is comparable to other studies that have been done in this area. Ajay et al. (1999) used a database of over 9,000 molecules and achieved an 80% predictivity. The prediction methods of Luco (1999) and Crivori (2000) based on threedimensional structure analysis both achieved around 90% predictivity. The SVM algorithm is impressive because even with a very small data set it performs comparably to the other methods used.
The SVM algorithm is also advantageous because it accurately classi es both CNS active and CNS inactive compounds. The neural network correctly classi ed 81.5% of the CNS active and 69.9% of the inactive molecules. The neural network used by Ajay correctly classi ed 92% of the CNS active molecules, but only 71% of the inactive molecules. The SVM correctly classi ed 82.7% and 80.2% of the CNSC and CNS¡ compounds, respectively, suggesting that the SVM is better able to handle classi cation problems such as the one described here.
An assumption that has been made for the prediction algorithms is that BBB permeability is equated with pharmacological activity in the CNS. However, this simpli ed assumption may not be true for some molecules, where CNS inactivity is not necessarily due to an inability to cross the BBB but due to the lack of target proteins such as receptors in the CNS. It is also possible that molecules can facilely penetrate the BBB but are then quickly removed from the CNS by the P-glycoproteins and other ef ux proteins present on the BBB. In the parameters used by this study, passive diffusion is the only method of transport considered. This can result in high predictive values even with molecules that transported quickly out of the CNS (hence, low CNS bioavailability) as these algorithms currently focus primarily on permeability.
AZT (azidovudine) is often a common example of a molecule that is able to penetrate the BBB by passive diffusion, but is then removed from the CNS by the ef ux proteins (Physician's Desk Reference). When AZT is tested using the SVM approach, an output of C1 is obtained, indicating that the network believes this molecule can penetrate the BBB. In this case, the network was trained correctly because AZT does indeed penetrate the BBB, but AZT's CNS bioavailability is low due to its rapid removal by transport mechanisms. To further increase the usability of the SVM approach, transport properties need to be accounted for, a complicated task as experimental data and fundamental understanding of speci c transport mechanisms that operate in the CNS are limited.
CONCLUSION
While SVMs are frequently being used in other disciplines, they are still being explored in the eld of medicinal chemistry. The results of this study show that SVMs can be used to improve current prediction methods for the BBB problem and many similar classi cation problems that are important in this eld. SVMs are advantageous over neural networks because they have faster training times, they are convex problems with no local minima, and most importantly, they appear to be better able to classify small data sets like this one.
The SVM algorithm described here is a good starting point for developing a method of screening potential drug molecules based on their ability to penetrate the BBB. The SVM will reliably indicate whether a molecule will cross the BBB and we are currently developing a method for generating a dependable, quantitative prediction of BBB permeability. 
APPENDIX A. THE DATABASE
